A selection visit was successfully completed to participate in a phase III clinical trial for sublingual immunotherapy of tree pollen allergy for children from 5 to 17 years old.
A selection visit was successfully completed to participate in a phase III clinical trial for sublingual immunotherapy of tree pollen allergy for children from 5 to 17 years old.
